Expansion Opportunity PharmaForce is expanding facilities in Ohio, signaling ongoing capacity growth and potential demand for contract manufacturing services, sterile fill-finish capabilities, and supply chain optimization partnerships.

Sterile Injectables Focus Specialization in sterile injectable products positions PharmaForce as a potential client for outsourcing formulation development, aseptic processing enhancements, regulatory filing support, and scale-up services for complex parenterals.

Parent Company Tie Being wholly owned by Luitpold Pharmaceuticals, a Daiichi Sankyo Group Company, suggests access to broader distribution networks and potential collaboration on global clinical programs, API sourcing, and cross-sell opportunities.

Mid market Profile Revenue in the mid tens of millions with 51-200 employees indicates a growing mid-market pharmaceutical manufacturer that could benefit from strategic consulting, ERP/quality system upgrades, and scalable contract manufacturing partnerships.

Tech & Compliance Current tech stack and emphasis on quality and equal opportunity hiring highlight opportunities to offer digital GMP modernization, data analytics for batch release, and workforce training solutions to enhance compliance and operational excellence.